Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance.
- NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_assertion wasGeneratedBy ECO_0000203 NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance.
- NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_assertion wasDerivedFrom befree-20150227 NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance.
- NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_assertion SIO_000772 18690645 NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance.
- NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_assertion evidence source_evidence_literature NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance.
- NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_assertion description "[The CD44 variants modified by the sialyl Lewis a and sialyl Lewis x glycotopes are expected to have dual functions, serving as ligands for vascular selectins, and simultaneously having binding activity to vascular bed hyaluronate, and are expected to figure heavily in cancer metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414820.RA-p5DdgSy90-_g2UoHjow7iTfM4RBv4o8TRO07Jd16t4130_provenance.